SC
Savant Capital Portfolio holdings
AUM
$16.1B
1-Year Return
14.38%
This Quarter Return
+8.8%
1 Year Return
+14.38%
3 Year Return
+48.07%
5 Year Return
+73.78%
10 Year Return
+154.4%
AUM
$16.1B
AUM Growth
+$2.32B
(+17%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
7.67%
Top 10 Holdings %
Top 10 Hldgs %
39.16%
Holding
1,981
New
393
Increased
869
Reduced
537
Closed
138
Top Buys
| 1 |
Dimensional US Large Cap Value ETF
DFLV
|
+$115M |
| 2 |
Vanguard Growth ETF
VUG
|
+$88.4M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$87.8M |
| 4 |
Dimensional US Small Cap Value ETF
DFSV
|
+$70.4M |
| 5 |
Vanguard Total Bond Market
BND
|
+$64.8M |
Top Sells
| 1 |
Dimensional US Marketwide Value ETF
DFUV
|
+$24.4M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$15M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$12.6M |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$11.1M |
| 5 |
SW
Smurfit Westrock plc
SW
|
+$9.82M |
Sector Composition
| 1 | Technology | 6.06% |
| 2 | Financials | 3.47% |
| 3 | Industrials | 3% |
| 4 | Consumer Discretionary | 2.46% |
| 5 | Healthcare | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Gannett
GCI
$601M
| $49.5K | ﹤0.01% |
+13,839
| New | +$49.5K |
|
1802
Rocket Pharmaceuticals
RCKT
$346M
| $46.2K | ﹤0.01% |
+18,837
| New | +$46.2K |
|
1803
Berry Corp
BRY
$246M
| $45.9K | ﹤0.01% |
+16,588
| New | +$45.9K |
|
1804
Rayonier Advanced Materials
RYAM
$401M
| $45.2K | ﹤0.01% |
11,746
-28,752
| -71% | -$111K |
|
1805
Definitive Healthcare
DH
$430M
| $45.2K | ﹤0.01% |
+11,590
| New | +$45.2K |
|
1806
Puma Biotechnology
PBYI
$237M
| $44.5K | ﹤0.01% |
+12,971
| New | +$44.5K |
|
1807
Coherus Oncology, Inc. Common Stock
CHRS
$156M
| $44.3K | ﹤0.01% |
60,553
-55,238
| -48% | -$40.4K |
|
|
CNF
1808
CNFinance Holdings Limited American Depositary Shares, each representing two hundred (200) Ordinary Shares
CNF
$21M
| $43K | ﹤0.01% |
66,140
| – | – |
|
1809
Leslie's
LESL
$63.8M
| $41K | ﹤0.01% |
+97,738
| New | +$41K |
|
1810
Larimar Therapeutics
LRMR
$332M
| $38.9K | ﹤0.01% |
+13,444
| New | +$38.9K |
|
1811
C4 Therapeutics
CCCC
$191M
| $37.7K | ﹤0.01% |
+26,347
| New | +$37.7K |
|
1812
Prime Medicine
PRME
$734M
| $37.5K | ﹤0.01% |
+15,166
| New | +$37.5K |
|
1813
Sutro Biopharma
STRO
$82.7M
| $37.4K | ﹤0.01% |
+52,416
| New | +$37.4K |
|
1814
Enel Chile
ENIC
$5.05B
| $37K | ﹤0.01% |
+10,193
| New | +$37K |
|
1815
Geron
GERN
$868M
| $36.8K | ﹤0.01% |
26,074
+11,074
| +74% | +$15.6K |
|
1816
Nkarta
NKTX
$148M
| $36.5K | ﹤0.01% |
+21,986
| New | +$36.5K |
|
1817
Caribou Biosciences
CRBU
$170M
| $36.5K | ﹤0.01% |
+28,953
| New | +$36.5K |
|
1818
Zura Bio
ZURA
$143M
| $34K | ﹤0.01% |
32,409
+21,249
| +190% | +$22.3K |
|
|
EU
1819
enCore Energy
EU
$432M
| $30K | ﹤0.01% |
10,500
| – | – |
|
1820
Nordic American Tanker
NAT
$675M
| $28.4K | ﹤0.01% |
+10,814
| New | +$28.4K |
|
1821
Fate Therapeutics
FATE
$113M
| $27.1K | ﹤0.01% |
+24,205
| New | +$27.1K |
|
1822
Upland Software
UPLD
$70.5M
| $26.3K | ﹤0.01% |
13,500
| – | – |
|
1823
Plug Power
PLUG
$1.64B
| $25.9K | ﹤0.01% |
17,364
+982
| +6% | +$1.46K |
|
1824
Werewolf Therapeutics
HOWL
$62.6M
| $23.2K | ﹤0.01% |
+21,275
| New | +$23.2K |
|
|
ONL
1825
Orion Office REIT
ONL
$169M
| $23.1K | ﹤0.01% |
10,862
-770
| -7% | -$1.64K |
|